| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |